Sofamor and Xomed form ENT (ear, nose and throat) distribution deal:
This article was originally published in Clinica
Executive Summary
Xomed is to have exclusive, worldwide distribution rights to an ENT image-guided surgery system developed by Sofamor Danek. The product, which will be marketed as the Xomed ENT image-guided system, provides 3D images in real-time. The product will be compatible with Xomed's StraightShot powered tissue resection system. Memphis, Tennessee-based Sofamor will carry out development and manufacturing of the product, while Xomed, of Jacksonville, Florida, will sell through its 89-strong direct sales force and over 100 international distributors.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.